Functional MRI may be less than meets the eye

November 22, 2016

Functional MRI (fMRI) imaging has been a powerful tool for visualizing processing of information in the brain. This technique is based on the observation that the MRI signal changes with changes in the amount of blood flowing to a particular region of the brain, which correlates with the activity of that brain region. This is a very sophisticated technique that relies on complicated computer algorithms and this is where the problem lies.

A review of the three most popular software processing packages suggested that false-positive results are present in up to 70% of studies, which means up to 40,000 published trials may provide erroneous results. This review was published in the Proceedings of the National Academy of Sciences.

fMRI reports often provide tantalizing details about the effect of emotions, thoughts, drugs, etc on the brain. I searched through my posts and found three “Expect relief and you will get it“, “Botox helps headaches, makes you happier“, and “Science of acupuncture“.

This is not to say that all of this research is worthless. However, I would be skeptical of studies that involve a small number of subjects and from centers not known for rigorous scientific research.

Written by
Alexander Mauskop, MD
Continue reading
June 4, 2026
Research
A New Study of Meat Intake, Genetics, and Brain Health
A newly published Swedish study suggests that the relationship between diet and brain aging may be more genetically specific than previously understood. Researchers followed over 2,000 older adults for up to 15 years and found that higher meat consumption was associated with slower cognitive decline and lower dementia risk, but only in those carrying the APOE E4 genetic variant, the most common hereditary risk factor for Alzheimer's disease. This may be relevant for people with headaches.
Read article
June 3, 2026
News
Keynote address at the 22nd Annual Neuroscience Zappulla Research Day
I was honored to be delivering the keynote address at the 22nd Annual Neuroscience Zappulla Research Day on Wednesday, June 3, at the Hackensack Meridian Neuroscience Institute, JFK University Medical Center in Edison, NJ.
Read article
May 26, 2026
News
Why I Rarely Prescribe Topiramate, and What the New Data Shows
A new real-world study of 661 patients found that 67% stopped taking topiramate within six months, compared to 30% on candesartan. Candesartan also had a higher responder rate. Topiramate is FDA-approved; candesartan is not. The data makes the case for rethinking that priority.
Read article
Insights from Dr. Alexander Mauskop on headaches and migraines
Subscribe to the Blog.
Subscribe
Subscribe